Stein, E., DiNardo, C., Fathi, A., Mims, A., Pratz, K., Savona, M., Stein, A. S., Stone, R., Winer, E., Seet, C., Döhner, H., Pollyea, D., McCloskey, J., Odenike, O., Lowenberg, B., Ossenkoppele, G. J., Roshal, M., Choe, S., Meng, Q., Kapsalis, S., Patel, P., Kantarjian, H., Tallman, M. (2025). Updated response and safety analyses from a Phase 1 study of ivosidenib combined with intensive chemotherapy in patients with newly diagnosed (ND) Acute Myeloid Leukemia with isocitrate dehydrogenase (IDH)1 mutation. Blood. https://doi.org/10.1182/blood-2025-992